Grant: CIHR Fellowship
Direct Payment
$150,000.00
Molecular characterisation of the HIV-2 and SIV Vpx proteins.
FY 2010-11
Summary
The human immunodeficiency virus (HIV) is the causative agent of acquired immunodeficiency syndrome (AIDS). The virus is estimated to infect 33 million people worldwide, with 2.5 million new infections a year. In addition, 2 million deaths a year are attributed to AIDS. HIV encodes several accessory proteins that have been found to antagonise host restriction factors that would otherwise affect viral replication and infectivity. This project proposed to undergo the molecular characterisation of Vpx, an accessory protein unique to HIV-2 and SIV (simian immunodeficiency virus). It has been demonstrated that this viral protein is required for viral infectivity in macrophages, a cell type that has a major role in the dissemination and persistence of HIV, however, many questions remain concerning the functional mechanism of action of Vpx during viral replication. We believe that functional characterisaton of Vpx will lead to further understanding of the requirements for viral infection of macrophages and help to better understand the differences in virus-host interactions between HIV-2 and HIV-1 (which does not encode Vpx). This may help to understand why HIV-2 is less prevalent and generally less pathogenic than HIV-1 and may allow the development of strategies to reduce the pathogenic potential of HIV-1.
Department
Program
CIHR Fellowship
Recipient
Location
Maryland, United States of America
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
226959
Name
Welbourn Sarah
Region
Maryland
Country
United States of America
Orgtype
Research Institution
Instname2
Infection and Immunity
Theme2
Biomedical
Prcname2
Fellowships - Post-PhD
Projecttitle
Molecular characterisation of the HIV-2 and SIV Vpx proteins.
Programtype2
Fellowship Programs
Orgnameinp2
Direct Payment
Cihramount2
$150,000
Cihrequipment2
$0
Programname2
CIHR Fellowship
Keyworddelim
Accessory Proteins; Hiv; Macrophages; Molecular Virology; Restriction Factors; Vpx
Abstract
The human immunodeficiency virus (HIV) is the causative agent of acquired immunodeficiency syndrome (AIDS). The virus is estimated to infect 33 million people worldwide, with 2.5 million new infections a year. In addition, 2 million deaths a year are attributed to AIDS. HIV encodes several accessory proteins that have been found to antagonise host restriction factors that would otherwise affect viral replication and infectivity. This project proposed to undergo the molecular characterisation of Vpx, an accessory protein unique to HIV-2 and SIV (simian immunodeficiency virus). It has been demonstrated that this viral protein is required for viral infectivity in macrophages, a cell type that has a major role in the dissemination and persistence of HIV, however, many questions remain concerning the functional mechanism of action of Vpx during viral replication. We believe that functional characterisaton of Vpx will lead to further understanding of the requirements for viral infection of macrophages and help to better understand the differences in virus-host interactions between HIV-2 and HIV-1 (which does not encode Vpx). This may help to understand why HIV-2 is less prevalent and generally less pathogenic than HIV-1 and may allow the development of strategies to reduce the pathogenic potential of HIV-1.
Competitiondate
201102
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Welbourn, Sarah
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $150,000~ $0~